Lupus blood pressure breakthrough? new drug targets hidden immune trigger
NCT ID NCT07225543
First seen Nov 06, 2025 · Last updated Apr 28, 2026 · Updated 25 times
Summary
This study tests whether a supplement-like drug called 2-HOBA can lower blood pressure and reduce immune system overactivity in people with lupus. 42 adults with stable lupus and mildly high blood pressure will receive either the drug or a placebo for 4 weeks, then switch after a break. The goal is to understand if clearing certain inflammatory molecules can help control lupus-related health problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.